VERNALIS (R&D) LIMITED
Patent Owner
Stats
- 36 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 36 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 219 Total Citation Count
- Jan 23, 1995 Earliest Filing
- 13 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0002,313 ISOINDOLINE OR ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSep 14, 17Jan 04, 18[A61K, C07F, C07D, A61N]
2017/0342,051 INDOLE AND PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMAug 14, 17Nov 30, 17[A61K, C07D]
2017/0143,746 PHOSPHATE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMFeb 06, 17May 25, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9809574 Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing themJul 22, 14Nov 07, 17[A61K, C07F, C07D, A61N]
9765056 Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing themJul 22, 14Sep 19, 17[A61K, C07D]
9765080 Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonistsJun 02, 16Sep 19, 17[C07D]
9670227 Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing themDec 19, 14Jun 06, 17[A61K, C07D, A61N]
9603854 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing themJul 15, 15Mar 28, 17[A61K, C07D, A61N]
9604975 Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activityNov 10, 14Mar 28, 17[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0298,043 Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory ActivityAbandonedFeb 08, 17Oct 19, 17[A61K, C07D]
2010/0204,224 AZACYCLIC COMPOUNDS AS INHIBITORS OF SENSORY NEURONE SPECIFIC SODIUM CHANNELSAbandonedJul 07, 06Aug 12, 10[A61K, C07D, A61P]
2010/0010,037 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORSAbandonedAug 17, 07Jan 14, 10[A61K, C07D, A61P]
2009/0181,989 Purine Compunds as HSP90 Protein Inhibitors for the Treatment of CancerAbandonedFeb 27, 09Jul 16, 09[A61K, C07D, A61P]
2009/0131,470 PYRAZOLE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISORDERSAbandonedJun 06, 06May 21, 09[A61K, C07D, A61P]
2009/0054,421 Pyrimidothiophene Compounds Having HSP90 Inhibitory ActivityAbandonedJan 23, 06Feb 26, 09[A61K, C07D]
2008/0182,860 Pyrimidine Compounds as Purine Receptor AntagonistAbandonedFeb 11, 05Jul 31, 08[A61K, C07D, A61P]
5700838 Hydroxamic acid derivatives as metalloproteinase inhibitorsExpiredJan 23, 95Dec 23, 97[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.